@FAndreMD

Head of Research Division of @GustaveRoussy , @myesmo President

Joined October 2015
  • Tweets3.2K
  • Following498
  • Followers15.3K
430Media
Check out our Opinion paper in @Nature, where we write about: i) The decline in physician-scientist numbers worldwide ii) Why this might be, based on our own data and others’ iii) Steps to reverse the decline nature.com/articles/d41586-0… @rezamotallebov @CharlesSwanton @bealelab

Keep medical doctors in academia — without them, health-care research will suffer

Nature - Better career support and more funding stability is needed to retain this invaluable group of scientists.

nature.com
3
27
4
43
10,169
FabriceAndre retweeted
ESMO - Eur. Oncology
@myESMOSep 10
ESMO's new Clinical Trials Funding initiative supports independent academic pragmatic clinical trials to improve #CancerCare and patient outcomes. Open to academic institutions, hospitals, research groups. Application deadline: 1 November 2026 ow.ly/482Q50ZLX3p
1
18
10
42
15,568
.@esmo_iotech publishes innovations in immuno-oncology. high quality papers under the leadership of @LoiSher and @HaanenJohn
Sherene Loi, MD
@LoiSherAug 10
🚩Can an mRNA vaccine make “cold” tumours more responsive to immunotherapy 🌶️? A recent @Nature study suggests mRNA vaccination may activate systemic innate immunity & potentially sensitise tumours to checkpoint blockade. The clinical data need prospective validation, but the biological concept is compelling. The Authors discuss the implications in an @esmo_iotech commentary. 🙏@adam_grippin @StevenLin_MDPhD Nature article linked: nature.com/articles/s41586-0… IOTECH commentary: esmoiotech.org/article/S2590… @myESMO @esmo_iotech #CancerImmunotherapy #mRNA #ImmunoOncology #ESMO #ESMOIOTECH

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

Nature - mRNA vaccines targeting SARS-CoV-2 also sensitize tumours to immune checkpoint inhibitors.

nature.com
5
8
3,077
FabriceAndre retweeted
Toni Choueiri, MD
@DrChoueiriAug 4
I enjoyed going through this paper by @FerMosele and @GustaveRoussy team. It outlines a roadmap for the future of ADCs from soup to nuts. It was just published in @NatureMedicine —a must read for everyone with @FIFAWorldCup ⚽️ withdrawal! Link: nature.com/articles/s41591-0…
3
32
111
10,226
FabriceAndre retweeted
Élysée
@ElyseeJul 14
EN DIRECT | Cérémonie en hommage aux victimes de l’attentat du 14 juillet 2016 à Nice. xitter.cf/i/broadcasts/1nJOLLqdb…
0:00

Élysée

EN DIRECT | Cérémonie en hommage aux victimes de l’attentat du 14 juillet 2016 à Nice.

145
190
11
543
88,023
FabriceAndre retweeted
Nice-Matin
@Nice_MatinJul 13
Voici la une de Nice-Matin de ce mardi 14 juillet 2026.
9
339
27
942
60,586
Wow! Not 1️⃣, not 2️⃣, but 3️⃣‼️@Nature papers concomitantly published during #ESMO25 @myESMO @LoiSher @adam_grippin @MDAndersonNews @PeterMacCC @NKI_nl @DrChoueiri @VanAllenLab @FAndreMD congrats to all authors and 🙏 for making this very unique session happen also @Nature ! 👇
6
31
1
140
16,404
📣 ESMOImmuno25: Aurélien Marabelle, Scientific Co-Chair, invites you to present your research to an international audience of top-tier scientists, clinicians, and industry experts. ⏰ Deadline: 30 September 2025 🔗 ow.ly/PXBG50WnEQ4
1
5
14
3,351
📣 Join us in Hong Kong for a chance to contribute to oncology drug development in Asia Pacific! ⏰ Late registration deadline: 18 June 🔗 ow.ly/MWyG50W90Ef @herbloong @TonyMok9 @DrBenTran @AyaHelali
7
24
2,837
FabriceAndre retweeted
ASCO
@ASCO19 May 2025
At #ASCO25, the Joint Session between ASCO and @myESMO will discuss emerging trends & the implications of integrating biomarker testing into clinical care. #ASCODailyNews has more on this with: @ASCOPres @BenWestphalen @FAndreMD @DrBonillaOnc @jrgralow: brnw.ch/21wSLDe
2
20
1
54
6,627
#ESMOBreast25 is next month. Love this "digestible" breast only meeting with the benefits of extra interaction with all of our international colleagues. Registration: esmo.org/meeting-calendar/es… Program: cslide.ctimeetingtech.com/co… #bcsm @myESMO @curijoey @FAndreMD
2
16
1
74
4,402
📢 #ESMOFellowship applications are now open! The Society is committed to supporting #YoungOncologists in developing high-quality #TranslationalResearch or #ClinicalResearch projects. 📅 Apply by: 29 May 2025 🔗 ow.ly/tz3e50VAQuM @E_de_Azambuja @TeresaSAmaral
16
2
44
14,438
It was very sad to learn that M Schneider passed away. Maurice created @myESMO in 1975 together with G Mathe, in @VilledeNice 50 years later, @myESMO includes almost 45k members around the 🌍, trains all generations of doctors and transforms practice of oncology w its frameworks
ESMO - Eur. Oncology
@myESMO9 Apr 2025
ESMO pays tribute to Dr Maurice Schneider who dedicated his life to advancing oncology. His efforts were instrumental in paving the way for future generations of medical oncology professionals across Europe.
7
8
64
4,029
📣ESMO #ClinicalPracticeGuideline Express Update on #PancreaticCancer: updated 1st- & #2nd-line treatment recommendations for managing #MetastaticPancreaticCancer, following approval of 1st-line nanoliposomal #irinotecan. #ESMOGuidelines 🔗ow.ly/H7Ap50Vx9Qj
2
18
2
44
8,035
👉 Share your findings with regional and international experts in #cancer #drugdevelopment. ⏰ You still have 3 weeks to submit your abstract to #ESMOTATAsia25, a new platform to improve cancer care in the region Submit now: 🔗 ow.ly/iagq50VuAmn
9
17
2,417
Abstract submission now open for #ESMO25 in #BERLIN! We have a fantastic educational programme in place, and now it's time for the scientific programme. Looking forward to your abstracts! Deadline: May13th esmo.org/meeting-calendar/es… @DrChoueiri @myESMO @DrChoueiri @FAndreMD
4
37
4
111
13,847
📣 Join us for an insightful ESMO Webinar on Advanced Urothelial Cancer! 👩‍⚕️Our expert panel will discuss 1st & 2nd line therapies, toxicity management & more. Live Q&A included. 👉Register now! #UrothelialCancer 🔗ow.ly/Etpg50V07hR
10
2
21
3,937
📣 ESMO #ClinicalPracticeGuideline eUpdate on #OesophagealCancer: in resectable, locally advanced oesophageal adenocarcinoma or OGJ pre- & post-operative #chemotherapy is associated with improved survival vs #Neoadjuvant #Chemoradiotherapy. 🔗 ow.ly/R37w50UYlE9
2
21
29
3,300
Opening session of #ESMOAFrica2025 by the @myESMO president @FAndreMD with the amazing audience from all over Africa. @OncoAlert @curijoey @E_de_Azambuja
1
4
19
1,513
Get the latest in early clinical trials at ESMO TAT 2025, from bispecific antibodies for IO, cell therapies in solid tumours (CART, NK cells, modified TCRs, TIL therapy) to MAPkinase pathway and associated targets (KRAS G12C, MAP2K4, combos). Register now!

2
21
3
121
434,673
Load more